0001562180-20-004289.txt : 20200604
0001562180-20-004289.hdr.sgml : 20200604
20200604174417
ACCESSION NUMBER: 0001562180-20-004289
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200602
FILED AS OF DATE: 20200604
DATE AS OF CHANGE: 20200604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davidson David
CENTRAL INDEX KEY: 0001578696
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35966
FILM NUMBER: 20943907
MAIL ADDRESS:
STREET 1: C/O BLUEBIRD BIO, INC.
STREET 2: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: bluebird bio, Inc.
CENTRAL INDEX KEY: 0001293971
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc
DATE OF NAME CHANGE: 20040616
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-06-02
false
0001293971
bluebird bio, Inc.
BLUE
0001578696
Davidson David
C/O BLUEBIRD BIO, INC.
60 BINNEY STREET
CAMBRIDGE
MA
02142
false
true
false
false
Chief Medical Officer
Common Stock
2020-06-02
4
S
false
10.00
63.3626
D
39924.00
D
Common Stock
2020-06-02
4
S
false
32.00
64.2432
D
39892.00
D
Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
The range in prices for the transaction reported on this line was $62.76 to $63.57. The average weighted price was $63.3626. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range in prices for the transaction reported on this line was $63.76 to $64.30. The average weighted price was $64.2432. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Helen C. Fu, Attorney-in-Fact
2020-06-04